Infections in 252 patients with common variable immunodeficiency

Clinical Infectious Diseases

Volumn 46, Issue 10, 2008, Pages 1547-1554

  Oksenhendler, Eric ^a   Gérard, Laurence ^a   Fieschi, Claire ^a   Malphettes, Marion ^a   Mouillot, Gael ^b   Jaussaud, Roland ^d   Viallard, Jean François ^e   Gardembas, Martine ^f   Galicier, Lionel ^a   Schleinitz, Nicolas ^g   Suarez, Felipe ^c   Soulas Sprauel, Pauline ^h   Hachulla, Eric ⁱ   Jaccard, Arnaud ^j   Gardeur, Anaelle ^a   Théodorou, Ioannis ^b   Rabian, Claire ^a   Debré, Patrice ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d SERVICE DE DERMATOLOGIE   (France)

^e HAUT LÉVÊQUE HOSPITAL   (France)

^f ANGERS UNIVERSITY HOSPITAL   (France)

^g HÔPITAL DE LA CONCEPTION   (France)

^h INSERM   (France)

ⁱ LILLE UNIVERSITY HOSPITAL   (France)

^j DUPUYTREN UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; BRONCHIECTASIS; BRONCHITIS; CHRONIC DIARRHEA; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COMMON VARIABLE IMMUNODEFICIENCY; CORRELATION ANALYSIS; DELAYED DIAGNOSIS; FEMALE; GENE FREQUENCY; GENE MUTATION; GIARDIASIS; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNOGLOBULIN DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; OPPORTUNISTIC INFECTION; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT INFECTION; RETROSPECTIVE STUDY; SALMONELLOSIS; SINUSITIS; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION; ADOLESCENT; AGE; AGED; BLOOD; CHILD; COMMUNICABLE DISEASE; DIARRHEA; MIDDLE AGED; PREVALENCE; RESPIRATORY TRACT INFECTION; TIME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; COMMUNICABLE DISEASES; DIARRHEA; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PNEUMONIA; PREVALENCE; RESPIRATORY TRACT INFECTIONS; TIME FACTORS;

EID: 43249086529     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/587669     Document Type: Article

References (27)

1. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999; 93:190-7.
2. Hammarstrom L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000; 120:225-31.
3. -) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002; 99:1544-51.
4. Piqueras B, Lavenu-Bombled C, Galicier L, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 2003; 23:385-400.
5. Wehr C, Kivioja T, Schmitt C, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008; 111:77-85.
6. Salzer U, Maul-Pavicic A, Cunningham-Rundles C, et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 2004; 113:234-40.
7. van Zelm MC, Reisli I, van der Burg M, et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006; 354:1901-12.
8. Grimbacher B, Hutloff A, Schlesier M, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency.Nat Immunol 2003; 4:261-8.
9. Castigli E, Wilson SA, Garibyan L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005; 37:829-34.
10. Salzer U, Chapel HM, Webster AD, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005; 37:820-8.
11. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. QJ Med 1993; 86:31-42.
12. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92:34-48.
13. Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007; 27:308-16.
14. Quinti I, Pierdominici M, Marziali M, et al. European surveillance of immunoglobulin safety - results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries. Clin Immunol 2002; 104:231-6.
15. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002; 109:1001-4.
16. Quartier P, Debre M, De Blic J, et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr 1999; 134:589-96.
17. Bjorkander J, Wadsworth C, Hanson LA. 1040 Prophylactic infusions with an unmodified intravenous immunoglobulin product causing few side-effects in patients with antibody deficiency syndromes. Infection 1985; 13:102-10.
18. de Gracia J, Vendrell M, Alvarez A, et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Immunopharmacol 2004; 4:745-53.
19. Pourpak Z, Aghamohammadi A, Sedighipour L, et al. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency. J Microbiol Immunol Infect 2006; 39:114-20.
20. Eijkhout HW, van Der Meer JW, Kallenberg CG, et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia: a randomized, double-blind, multicenter crossover trial. Ann Intern Med 2001; 135:165-74.
21. Pahari A, Pal C, Lyall H. Recurrent meningitis in association with common variable immune deficiency. Indian Pediatr 2004; 41:1152-4.
22. Onbasi K, Gunsar F, Sin AZ, Ardeniz O, Kokuludag A, Sebik F. Common variable immunodeficiency (CVID) presenting with malabsorption due to giardiasis. Turk J Gastroenterol 2005; 16:111-3.
23. Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 2005; 25:57-62.
24. Michel M, Chanet V, Galicier L, et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) 2004; 83:254-63.
25. Lidove O, Gervais A, Malphettes M, Sauvanet A, Moretti JL, Papo T. Infection after cyanoacrylate injection: a fatal complication in a patient with portal hypertension associated with common variable immunodeficiency. Endoscopy 2007; 39(Suppl 1):E180-1.
26. Mahevas M, Le Page L, Salle V, et al. Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency. Am J Hematol 2006; 81:645-6.
27. Alachkar H, Taubenheim N, Haeney MR, Durandy A, Arkwright PD. Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin Immunol 2006; 120:310-8.